Loading organizations...
Biotech company specializing in nucleic acid therapeutics delivery.
Solstice Biologics has raised $22.0M across 2 funding rounds.
Solstice Biologics has raised $22.0M in total across 2 funding rounds.
Solstice Biologics has raised $22.0M in total across 2 funding rounds.
Solstice Biologics's investors include George Rehm.
Solstice Biologics has raised $22.0M across 2 funding rounds. Most recently, it raised $4.0M Other Equity in December 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 30, 2015 | $4.0M Other Equity | ||
| Jan 4, 2013 | $18.0M Series A | George Rehm |